The Biotech Hall of Shame

March 10, 2017

(Managed Care Magazine) – FierceBiotech has issued its picks for 2016’s nine worst biotech companies. The list presents a sobering panorama of deaths in clinical trials, falling share prices wiping out value and confidence, deal-making blunders, epic fails, trillion-dollar opportunities lost, and fundamental technology falling short.